CBU
RYTM icon

CIBC Bancorp USA’s Rhythm Pharmaceuticals RYTM Stock Holding History

CIBC Bancorp USA’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$338K Buy
3,048
+385
+14% +$34.8K ﹤0.01% 1475
2026
Q1 		$232K Buy
+2,663
New +$259K ﹤0.01% 1542
2025
Q3 		$562K Buy
+5,569
New +$517K ﹤0.01% 818

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

CIBC Bancorp USA's RYTM Position: Q2 2026 in Review

CIBC Bancorp USA increased its Rhythm Pharmaceuticals (RYTM) stake by 14% in Q2 2026, buying an estimated $34.8K and bringing the position to 3,048 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #1475.

CIBC Bancorp USA first reported a position in RYTM in Q3 2025 and has held it in 3 quarters since. The position peaked at $562K in Q3 2025. 280 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • CIBC Bancorp USA held 3,048 shares of Rhythm Pharmaceuticals worth $338K as of Q2 2026.
  • CIBC Bancorp USA bought 385 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $34.8K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1475 holding.
  • CIBC Bancorp USA first reported a position in Rhythm Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Rhythm Pharmaceuticals position peaked at $562K in Q3 2025.
  • 280 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.